Schedule of common stock warrants (Details) - shares |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Class of Warrant or Right [Line Items] | ||
| Exercised | 0 | |
| Series D Common Stock Warrants [Member] | ||
| Class of Warrant or Right [Line Items] | ||
| Outstanding at December 31, 2023 | 4,250,000 | 6,250,000 |
| Issued | ||
| Exercised | 2,000,000 | |
| Outstanding at March 31, 2024 | 4,250,000 | 4,250,000 |
| Series H Warrants [Member] | ||
| Class of Warrant or Right [Line Items] | ||
| Outstanding at December 31, 2023 | 413,512 | 413,512 |
| Issued | ||
| Canceled | ||
| Exercised | ||
| Outstanding at March 31, 2024 | 413,512 | 413,512 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|